BTIG Reiterates Buy on OrthoPediatrics, Maintains $24 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 90.1%

Neg 0% Neu 90.1% Pos 0%

BTIG analyst Ryan Zimmerman reiterates OrthoPediatrics (NASDAQ:KIDS) with a Buy and maintains $24 price target.

Comments

No comments yet. Be the first!